相关实验视频
Updated: Jul 19, 2025

05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
3.8K
治疗偏头痛疾病的非CGRP对手/非三子选择:临床考虑
Ellen E Ingram1, Brooke E Bocklud2, Sarah C Corley1
1School of Medicine, Louisiana State University Health Sciences Center at New Orleans, New Orleans, LA, 70112, USA.
Current pain and headache reports
|August 16, 2023
概括
非CGRP和非triptan药物提供有效的偏头痛治疗选择. 本综述评估了NSAID,β-阻断剂和其他用于急性和预防性偏头痛治疗的药物,并比较了它们的益处和风险.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛治疗通常集中在CGRP途径上,但还有其他治疗选择.
- 了解各种机制是有效管理偏头痛症状的关键.
研究的目的:
- 审查非CGRP抗剂/非三类药物治疗偏头痛的药理选择.
- 评估治疗急性症状和预防的疗法,包括不良影响.
主要方法:
- 对非CGRP抗剂/非三类偏头痛疗法的审查.
- 对NSAIDs,β-阻断剂,通道阻断剂,抗抑郁药和抗药的评估.
- 对急性和预防性治疗的不良影响的比较.
主要成果:
- 美国食品和药物管理局批准的偏头痛预防药物包括propranolol,timolol,topiramate和divalproex.
- 无 NSAIDs 在急性治疗中是有效的;β-阻断剂用于预防,具有特定的禁忌.
- 抗药和抗抑郁药对预防有效,但有副作用;通道阻断剂缺乏足够的预防证据.
结论:
- 治疗决策需要考虑禁忌,有效性和副作用.
- 风险效益分析和患者与医生的讨论对于药理管理至关重要.
- 非CGRP/非triptan选项为偏头痛管理提供了有价值的替代方案.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
776
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
776
Cholinergic Antagonists: Pharmacokinetics
516
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
516
Drugs Acting on Autonomic Ganglia: Blockers
1.1K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.1K
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
243
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
243

